Diagnostics

Community-acquired pneumonia (CAP) is the most common fatal infectious disease in western countries. Bacteria are the most common pathogens causing CAP, where one differentiates between typical [...]

RIDASCREEN® IFX Monitoring is an enzyme linked immunoassay intended for the quantitative determination of infliximab (IFX, anti-TNFα) in human serum and plasma. 

Human parainfluenza viruses (HPIV) can cause both upper respiratory infections and lower respiratory infections.

RIDA®GENE Enterovirus – the new real-time RT-PCR assay for the detection of the major human enteroviruses

About 50 % of Type-1-Diabetics, 33 % Type-2-Diabetics and 75 – 80 % Mucoviscidosis patients develop exocrine pancreatic insufficiency in the course of their illness (Hardt PD, [...]

R-Biopharm AG has faced the challenge to develop a sophisticated allergy in vitro test system that combines both a quantitative determination and a very economic and easy handling.

New line blot immunoassays – reliable differentiation between human IgG and IgA antibodies against Helicobacter pylori type I and II strains

R-Biopharm (Darmstadt) has brought to the market the fastest assay currently available for the specific detection of enterohemorrhagic Escherichia coli (EHEC). With the new RIDA®GENE EHEC/EPEC [...]

The Danish company REFLAB became a member of the R-Biopharm group on January 1, 2010. As a supplier of test kits for the detection of autoreactive urticaria and histamine release tests for the [...]